Evaluation and Management of a 28-Year-Old Male with Diffuse Body Pain
Begin with a comprehensive biopsychosocial assessment that includes pain characteristics, red flag screening for serious underlying conditions, psychosocial factors, and functional impact, followed by targeted physical examination and minimal initial laboratory testing. 1
Initial Assessment Framework
Pain Characterization
- Document pain severity, duration, location (localized vs. diffuse), quality, onset pattern, and temporal characteristics 1
- Ask specifically: "How much bodily pain have you had during the last week?" (none to very severe scale) and "Do you have body pain that has lasted for more than 3 months?" 1
- Moderate pain or greater lasting >3 months constitutes a positive screen for chronic pain requiring more intensive evaluation 1
- Differentiate between localized and generalized pain patterns, as these may coexist and require different management approaches 1
Red Flag Screening for Serious Pathology
Immediately assess for life-threatening or serious underlying conditions:
- Constitutional symptoms: Unexplained weight loss, night sweats, fever suggesting malignancy, infection, or systemic inflammatory disease 1, 2
- Neurological deficits: Progressive weakness, saddle anesthesia, bowel/bladder dysfunction indicating cauda equina syndrome or spinal cord pathology 1, 2
- Inflammatory markers: Consider polymyalgia rheumatica (common in older adults but can occur in younger patients), systemic lupus erythematosus, rheumatoid arthritis 3, 4
- Endocrine disorders: Hypothyroidism, other endocrine abnormalities that can present as diffuse pain 4
- Medication-induced: Review for serotonergic agents (SSRIs, SNRIs, tramadol, ondansetron) that can cause serotonin syndrome presenting initially as diffuse body pain 5
Psychosocial Assessment
The British Pain Society emphasizes that psychosocial factors are stronger predictors of pain outcomes than physical findings or pain severity itself 1:
- Depression, anxiety, and catastrophizing: These predict poorer outcomes and delayed recovery 1
- Functional impact: Assess disability in activities of daily living, work status, social participation, sleep quality 1, 2
- Pain-related beliefs: Fear-avoidance behaviors, perceived control over pain, self-efficacy 1, 2
- Social factors: Job dissatisfaction, disputed compensation claims, family dynamics, economic stressors 1
- Substance use: Tobacco, alcohol, or drug dependence that may complicate management 1, 2
Physical Examination
Perform targeted examination based on pain distribution:
- Musculoskeletal: Joint tenderness, range of motion, muscle strength, trigger points 1
- Neurological: Reflexes, sensation, motor function, gait assessment 1, 2
- Systemic: Vital signs, general appearance, signs of systemic illness 1
Initial Diagnostic Testing
The British Pain Society and American College of Physicians recommend simple, targeted tests only—avoid continuous cycles of investigation 1:
- Erythrocyte sedimentation rate (ESR) or C-reactive protein (CRP): To screen for inflammatory conditions 1
- Complete blood count: To assess for infection, anemia, or hematologic disorders 4
- Thyroid function tests: Hypothyroidism commonly presents with diffuse pain 4
- Basic metabolic panel: To assess renal function and electrolytes 4
- Creatine kinase: If myopathy suspected 4
- Vitamin D level: Osteomalacia can present as diffuse pain 4
Do not routinely obtain imaging in the absence of specific indications—plain radiography and advanced imaging are not associated with improved outcomes in nonspecific pain 1
Management Approach
Immediate Management
- Analgesic management should begin as soon as possible when indicated—diagnosis should not delay analgesia 1
- Develop a personalized pain management plan collaboratively with the patient, including functional goals 1
Risk Stratification
Identify patients at risk for pain persistence or complexity:
- Presence of multiple psychosocial risk factors indicates "complex" pain requiring interdisciplinary care 1
- Consider early referral to pain management or multidisciplinary team for patients with:
Follow-up and Reassessment
- Reassess within 1 month if symptoms persist or fail to improve 1
- Monitor treatment response using standardized tools (Brief Pain Inventory or PEG scale) at regular intervals 1
- Document pain intensity, functional progress toward goals, adverse events, and medication adherence 1
Common Pitfalls to Avoid
- Do not assume fibromyalgia or nonspecific pain without excluding inflammatory, endocrine, neoplastic, and neurological causes 3, 4
- Do not overlook medication-induced causes, particularly serotonin syndrome in patients on multiple serotonergic agents 5
- Do not delay treatment while pursuing diagnosis—pain relief and functional restoration should proceed concurrently 1
- Do not use the term "chronic pain patient" as it may lead to failure to reassess for new or evolving pathology 1
- Do not order extensive imaging or repeated investigations without specific clinical indications—this does not improve outcomes and may lead to unnecessary interventions 1